Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
8801
8802
8803
8804
8805
8806
8807
8808
8809
8810
8811
8812
8813
8814
8815
8816
8817
8818
8819
8820
8821
8822
8823
8824
8825
8826
8827
8828
8829
8830
8831
8832
8833
8834
8835
8836
8837
8838
8839
8840
8841
8842
8843
8844
8845
8846
8847
8848
8849
8850
8851
8852
8853
8854
8855
8856
8857
8858
8859
8860
8861
8862
8863
8864
8865
8866
8867
8868
8869
8870
8871
8872
8873
8874
8875
8876
8877
8878
8879
8880
8881
8882
8883
8884
8885
8886
8887
8888
8889
8890
8891
8892
8893
8894
8895
8896
8897
8898
8899
8900
8901
8902
8903
8904
8905
8906
8907
8908
8909
8910
8911
8912
8913
8914
8915
8916
8917
8918
8919
8920
8921
8922
8923
8924
8925
8926
8927
8928
8929
8930
8931
8932
8933
8934
8935
8936
8937
8938
8939
8940
8941
8942
8943
8944
8945
8946
8947
8948
8949
8950
8951
8952
8953
8954
8955
8956
8957
8958
8959
8960
8961
8962
8963
8964
8965
8966
8967
8968
8969
8970
8971
8972
8973
8974
8975
8976
8977
8978
8979
8980
8981
8982
8983
8984
8985
8986
8987
8988
8989
8990
8991
8992
8993
8994
8995
8996
8997
8998
8999
9000
| UnnamedSample_HQ_transcript/7140|m.2905 | UnnamedSample_HQ_transcript/7140 | Coverage 0.165 too low. | 6a91826ec20cf8806421b1ad5043cfdb | 469 | Pfam | PF07727 | Reverse transcriptase (RNA-dependent DNA polymerase) | 308 | 455 | 6.7E-30 | T | 22-09-2020 | IPR013103 | Reverse transcriptase, RNA-dependent DNA polymerase |
| UnnamedSample_HQ_transcript/10454|m.3972 | UnnamedSample_HQ_transcript/10454 | Unmapped. | b1810adeaf384ea78ca69dc1211d175e | 1042 | Pfam | PF13086 | AAA domain | 950 | 1015 | 6.0E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/10454|m.3972 | UnnamedSample_HQ_transcript/10454 | Unmapped. | b1810adeaf384ea78ca69dc1211d175e | 1042 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 181 | 550 | 1.2E-9 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/21883|m.7393 | UnnamedSample_HQ_transcript/21883 | Coverage 0.690 too low. | 7eebbfbd8cd58719e43a40b5ee1821d8 | 504 | Pfam | PF01426 | BAH domain | 354 | 500 | 4.5E-13 | T | 22-09-2020 | IPR001025 | Bromo adjacent homology (BAH) domain |
| UnnamedSample_HQ_transcript/109350|m.23761 | UnnamedSample_HQ_transcript/109350 | Identity 0.941 too low. | d559c5cac56bb94b985f1e57dd0256ea | 128 | Pfam | PF06179 | Surfeit locus protein 5 subunit 22 of Mediator complex | 21 | 118 | 3.3E-32 | T | 22-09-2020 | IPR009332 | Mediator of RNA polymerase II transcription subunit 22 |
| UnnamedSample_HQ_transcript/11407|m.4296 | UnnamedSample_HQ_transcript/11407 | Coverage 0.825 too low. | 5669a6104b73db155bac450275be3392 | 682 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 95 | 345 | 3.5E-50 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/17599|m.6192 | UnnamedSample_HQ_transcript/17599 | Coverage 0.471 too low. | 603798008206e69b46072fd5dbb2210c | 297 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 127 | 177 | 1.8E-13 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/17599|m.6192 | UnnamedSample_HQ_transcript/17599 | Coverage 0.471 too low. | 603798008206e69b46072fd5dbb2210c | 297 | Pfam | PF00564 | PB1 domain | 12 | 93 | 2.1E-11 | T | 22-09-2020 | IPR000270 | PB1 domain |
| UnnamedSample_HQ_transcript/102188|m.22893 | UnnamedSample_HQ_transcript/102188 | Coverage 0.756 too low. | 78d835b4a46b5d68d9cf7ddd5ee3dce7 | 245 | Pfam | PF03227 | Gamma interferon inducible lysosomal thiol reductase (GILT) | 30 | 138 | 1.2E-26 | T | 22-09-2020 | IPR004911 | Gamma interferon inducible lysosomal thiol reductase GILT |
| UnnamedSample_HQ_transcript/57229|m.15491 | UnnamedSample_HQ_transcript/57229 | Coverage 0.894 too low. | 78d835b4a46b5d68d9cf7ddd5ee3dce7 | 245 | Pfam | PF03227 | Gamma interferon inducible lysosomal thiol reductase (GILT) | 30 | 138 | 1.2E-26 | T | 22-09-2020 | IPR004911 | Gamma interferon inducible lysosomal thiol reductase GILT |
| UnnamedSample_HQ_transcript/53389|m.14717 | UnnamedSample_HQ_transcript/53389 | Coverage 0.905 too low. | 78d835b4a46b5d68d9cf7ddd5ee3dce7 | 245 | Pfam | PF03227 | Gamma interferon inducible lysosomal thiol reductase (GILT) | 30 | 138 | 1.2E-26 | T | 22-09-2020 | IPR004911 | Gamma interferon inducible lysosomal thiol reductase GILT |
| UnnamedSample_HQ_transcript/71180|m.18143 | UnnamedSample_HQ_transcript/71180 | Coverage 0.858 too low. | 78d835b4a46b5d68d9cf7ddd5ee3dce7 | 245 | Pfam | PF03227 | Gamma interferon inducible lysosomal thiol reductase (GILT) | 30 | 138 | 1.2E-26 | T | 22-09-2020 | IPR004911 | Gamma interferon inducible lysosomal thiol reductase GILT |
| UnnamedSample_HQ_transcript/49924|m.14006 | UnnamedSample_HQ_transcript/49924 | Coverage 0.875 too low. | 78d835b4a46b5d68d9cf7ddd5ee3dce7 | 245 | Pfam | PF03227 | Gamma interferon inducible lysosomal thiol reductase (GILT) | 30 | 138 | 1.2E-26 | T | 22-09-2020 | IPR004911 | Gamma interferon inducible lysosomal thiol reductase GILT |
| UnnamedSample_HQ_transcript/74152|m.18676 | UnnamedSample_HQ_transcript/74152 | Coverage 0.875 too low. | 78d835b4a46b5d68d9cf7ddd5ee3dce7 | 245 | Pfam | PF03227 | Gamma interferon inducible lysosomal thiol reductase (GILT) | 30 | 138 | 1.2E-26 | T | 22-09-2020 | IPR004911 | Gamma interferon inducible lysosomal thiol reductase GILT |
| UnnamedSample_HQ_transcript/103103|m.23001 | UnnamedSample_HQ_transcript/103103 | Coverage 0.792 too low. | 78d835b4a46b5d68d9cf7ddd5ee3dce7 | 245 | Pfam | PF03227 | Gamma interferon inducible lysosomal thiol reductase (GILT) | 30 | 138 | 1.2E-26 | T | 22-09-2020 | IPR004911 | Gamma interferon inducible lysosomal thiol reductase GILT |
| UnnamedSample_HQ_transcript/54537|m.14954 | UnnamedSample_HQ_transcript/54537 | Coverage 0.836 too low. | 78d835b4a46b5d68d9cf7ddd5ee3dce7 | 245 | Pfam | PF03227 | Gamma interferon inducible lysosomal thiol reductase (GILT) | 30 | 138 | 1.2E-26 | T | 22-09-2020 | IPR004911 | Gamma interferon inducible lysosomal thiol reductase GILT |
| UnnamedSample_HQ_transcript/52305|m.14509 | UnnamedSample_HQ_transcript/52305 | Coverage 0.905 too low. | 78d835b4a46b5d68d9cf7ddd5ee3dce7 | 245 | Pfam | PF03227 | Gamma interferon inducible lysosomal thiol reductase (GILT) | 30 | 138 | 1.2E-26 | T | 22-09-2020 | IPR004911 | Gamma interferon inducible lysosomal thiol reductase GILT |
| UnnamedSample_HQ_transcript/56875|m.15420 | UnnamedSample_HQ_transcript/56875 | Coverage 0.902 too low. | 78d835b4a46b5d68d9cf7ddd5ee3dce7 | 245 | Pfam | PF03227 | Gamma interferon inducible lysosomal thiol reductase (GILT) | 30 | 138 | 1.2E-26 | T | 22-09-2020 | IPR004911 | Gamma interferon inducible lysosomal thiol reductase GILT |
| UnnamedSample_HQ_transcript/102474|m.22928 | UnnamedSample_HQ_transcript/102474 | Coverage 0.813 too low. | 78d835b4a46b5d68d9cf7ddd5ee3dce7 | 245 | Pfam | PF03227 | Gamma interferon inducible lysosomal thiol reductase (GILT) | 30 | 138 | 1.2E-26 | T | 22-09-2020 | IPR004911 | Gamma interferon inducible lysosomal thiol reductase GILT |
| UnnamedSample_HQ_transcript/86516|m.20722 | UnnamedSample_HQ_transcript/86516 | Coverage 0.858 too low. | 78d835b4a46b5d68d9cf7ddd5ee3dce7 | 245 | Pfam | PF03227 | Gamma interferon inducible lysosomal thiol reductase (GILT) | 30 | 138 | 1.2E-26 | T | 22-09-2020 | IPR004911 | Gamma interferon inducible lysosomal thiol reductase GILT |
| UnnamedSample_HQ_transcript/71311|m.18172 | UnnamedSample_HQ_transcript/71311 | Coverage 0.880 too low. | 78d835b4a46b5d68d9cf7ddd5ee3dce7 | 245 | Pfam | PF03227 | Gamma interferon inducible lysosomal thiol reductase (GILT) | 30 | 138 | 1.2E-26 | T | 22-09-2020 | IPR004911 | Gamma interferon inducible lysosomal thiol reductase GILT |
| UnnamedSample_HQ_transcript/52598|m.14568 | UnnamedSample_HQ_transcript/52598 | Coverage 0.874 too low. | 78d835b4a46b5d68d9cf7ddd5ee3dce7 | 245 | Pfam | PF03227 | Gamma interferon inducible lysosomal thiol reductase (GILT) | 30 | 138 | 1.2E-26 | T | 22-09-2020 | IPR004911 | Gamma interferon inducible lysosomal thiol reductase GILT |
| UnnamedSample_HQ_transcript/19412|m.6703 | UnnamedSample_HQ_transcript/19412 | Coverage 0.690 too low. | 389f7596e09bc8f10e8d36e816e8549c | 336 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 218 | 290 | 1.7E-14 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/19412|m.6703 | UnnamedSample_HQ_transcript/19412 | Coverage 0.690 too low. | 389f7596e09bc8f10e8d36e816e8549c | 336 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 72 | 159 | 1.8E-16 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/6012|m.2545 | UnnamedSample_HQ_transcript/6012 | Unmapped. | 07770ca6084d6ee3a2a53909f47fb3e4 | 1304 | Pfam | PF13087 | AAA domain | 135 | 306 | 1.1E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/299|m.244 | UnnamedSample_HQ_transcript/299 | Unmapped. | 07770ca6084d6ee3a2a53909f47fb3e4 | 1304 | Pfam | PF13087 | AAA domain | 135 | 306 | 1.1E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/152|m.144 | UnnamedSample_HQ_transcript/152 | Unmapped. | 07770ca6084d6ee3a2a53909f47fb3e4 | 1304 | Pfam | PF13087 | AAA domain | 135 | 306 | 1.1E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/17860|m.6260 | UnnamedSample_HQ_transcript/17860 | Coverage 0.666 too low. | 105b717f4edc569b112656f6bfa7f754 | 1002 | Pfam | PF02862 | DDHD domain | 738 | 943 | 5.2E-49 | T | 22-09-2020 | IPR004177 | DDHD domain |
| UnnamedSample_HQ_transcript/16885|m.5966 | UnnamedSample_HQ_transcript/16885 | Coverage 0.938 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00433 | Protein kinase C terminal domain | 394 | 430 | 3.0E-6 | T | 22-09-2020 | IPR017892 | Protein kinase, C-terminal |
| UnnamedSample_HQ_transcript/16885|m.5966 | UnnamedSample_HQ_transcript/16885 | Coverage 0.938 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00069 | Protein kinase domain | 468 | 725 | 2.3E-74 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/16885|m.5966 | UnnamedSample_HQ_transcript/16885 | Coverage 0.938 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00069 | Protein kinase domain | 112 | 370 | 9.4E-71 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/15545|m.5566 | UnnamedSample_HQ_transcript/15545 | Coverage 0.941 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00433 | Protein kinase C terminal domain | 394 | 430 | 3.0E-6 | T | 22-09-2020 | IPR017892 | Protein kinase, C-terminal |
| UnnamedSample_HQ_transcript/15545|m.5566 | UnnamedSample_HQ_transcript/15545 | Coverage 0.941 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00069 | Protein kinase domain | 468 | 725 | 2.3E-74 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/15545|m.5566 | UnnamedSample_HQ_transcript/15545 | Coverage 0.941 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00069 | Protein kinase domain | 112 | 370 | 9.4E-71 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/31463|m.9821 | UnnamedSample_HQ_transcript/31463 | Coverage 0.819 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00433 | Protein kinase C terminal domain | 394 | 430 | 3.0E-6 | T | 22-09-2020 | IPR017892 | Protein kinase, C-terminal |
| UnnamedSample_HQ_transcript/31463|m.9821 | UnnamedSample_HQ_transcript/31463 | Coverage 0.819 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00069 | Protein kinase domain | 468 | 725 | 2.3E-74 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/31463|m.9821 | UnnamedSample_HQ_transcript/31463 | Coverage 0.819 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00069 | Protein kinase domain | 112 | 370 | 9.4E-71 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/28791|m.9162 | UnnamedSample_HQ_transcript/28791 | Coverage 0.832 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00433 | Protein kinase C terminal domain | 394 | 430 | 3.0E-6 | T | 22-09-2020 | IPR017892 | Protein kinase, C-terminal |
| UnnamedSample_HQ_transcript/28791|m.9162 | UnnamedSample_HQ_transcript/28791 | Coverage 0.832 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00069 | Protein kinase domain | 468 | 725 | 2.3E-74 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/28791|m.9162 | UnnamedSample_HQ_transcript/28791 | Coverage 0.832 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00069 | Protein kinase domain | 112 | 370 | 9.4E-71 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/36925|m.11150 | UnnamedSample_HQ_transcript/36925 | Coverage 0.918 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00433 | Protein kinase C terminal domain | 394 | 430 | 3.0E-6 | T | 22-09-2020 | IPR017892 | Protein kinase, C-terminal |
| UnnamedSample_HQ_transcript/36925|m.11150 | UnnamedSample_HQ_transcript/36925 | Coverage 0.918 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00069 | Protein kinase domain | 468 | 725 | 2.3E-74 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/36925|m.11150 | UnnamedSample_HQ_transcript/36925 | Coverage 0.918 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00069 | Protein kinase domain | 112 | 370 | 9.4E-71 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/13717|m.5022 | UnnamedSample_HQ_transcript/13717 | Coverage 0.870 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00433 | Protein kinase C terminal domain | 394 | 430 | 3.0E-6 | T | 22-09-2020 | IPR017892 | Protein kinase, C-terminal |
| UnnamedSample_HQ_transcript/13717|m.5022 | UnnamedSample_HQ_transcript/13717 | Coverage 0.870 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00069 | Protein kinase domain | 468 | 725 | 2.3E-74 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/13717|m.5022 | UnnamedSample_HQ_transcript/13717 | Coverage 0.870 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00069 | Protein kinase domain | 112 | 370 | 9.4E-71 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/22382|m.7539 | UnnamedSample_HQ_transcript/22382 | Coverage 0.932 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00433 | Protein kinase C terminal domain | 394 | 430 | 3.0E-6 | T | 22-09-2020 | IPR017892 | Protein kinase, C-terminal |
| UnnamedSample_HQ_transcript/22382|m.7539 | UnnamedSample_HQ_transcript/22382 | Coverage 0.932 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00069 | Protein kinase domain | 468 | 725 | 2.3E-74 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/22382|m.7539 | UnnamedSample_HQ_transcript/22382 | Coverage 0.932 too low. | 88f5c30353b98c2d471c5cfd123fb6e6 | 785 | Pfam | PF00069 | Protein kinase domain | 112 | 370 | 9.4E-71 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/24972|m.8214 | UnnamedSample_HQ_transcript/24972 | Coverage 0.677 too low. | fcf0ac126f6c0b23303c6f77af6cb827 | 705 | Pfam | PF19056 | WD40 repeated domain | 327 | 542 | 2.0E-49 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/49795|m.13980 | UnnamedSample_HQ_transcript/49795 | Coverage 0.929 too low. | 41c371518b974c9a3116f47d51ccb9a7 | 408 | Pfam | PF00151 | Lipase | 140 | 355 | 8.2E-33 | T | 22-09-2020 | IPR013818 | Lipase/vitellogenin |
| UnnamedSample_HQ_transcript/36698|m.11094 | UnnamedSample_HQ_transcript/36698 | Coverage 0.947 too low. | a201f867d14826a959e9e53c9e6f9cfd | 760 | Pfam | PF00890 | FAD binding domain | 97 | 128 | 8.5E-6 | T | 22-09-2020 | IPR003953 | FAD-dependent oxidoreductase 2, FAD binding domain |
| UnnamedSample_HQ_transcript/36698|m.11094 | UnnamedSample_HQ_transcript/36698 | Coverage 0.947 too low. | a201f867d14826a959e9e53c9e6f9cfd | 760 | Pfam | PF00307 | Calponin homology (CH) domain | 532 | 634 | 8.5E-16 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/30424|m.9570 | UnnamedSample_HQ_transcript/30424 | Coverage 0.612 too low. | a20b1e8ddf24c72a76b32e89ab727640 | 666 | Pfam | PF06472 | ABC transporter transmembrane region 2 | 40 | 314 | 9.7E-88 | T | 22-09-2020 | IPR011527 | ABC transporter type 1, transmembrane domain |
| UnnamedSample_HQ_transcript/30424|m.9570 | UnnamedSample_HQ_transcript/30424 | Coverage 0.612 too low. | a20b1e8ddf24c72a76b32e89ab727640 | 666 | Pfam | PF00005 | ABC transporter | 448 | 588 | 9.8E-17 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/40698|m.12008 | UnnamedSample_HQ_transcript/40698 | Coverage 0.911 too low. | 470eadb5aa34ac51b43b44d41acef40a | 772 | Pfam | PF00063 | Myosin head (motor domain) | 1 | 675 | 1.6E-283 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/69152|m.17787 | UnnamedSample_HQ_transcript/69152 | Unmapped. | 63feaaf5b61311411a98d8b8b258e4b1 | 537 | Pfam | PF13086 | AAA domain | 445 | 510 | 2.5E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/74525|m.18744 | UnnamedSample_HQ_transcript/74525 | Unmapped. | 63feaaf5b61311411a98d8b8b258e4b1 | 537 | Pfam | PF13086 | AAA domain | 445 | 510 | 2.5E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/27845|m.8926 | UnnamedSample_HQ_transcript/27845 | Coverage 0.792 too low. | 736f53808c2babfa312c8da29be02102 | 794 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 3 | 61 | 1.2E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/27845|m.8926 | UnnamedSample_HQ_transcript/27845 | Coverage 0.792 too low. | 736f53808c2babfa312c8da29be02102 | 794 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 503 | 561 | 7.4E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/27845|m.8926 | UnnamedSample_HQ_transcript/27845 | Coverage 0.792 too low. | 736f53808c2babfa312c8da29be02102 | 794 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 116 | 171 | 6.7E-10 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/27845|m.8926 | UnnamedSample_HQ_transcript/27845 | Coverage 0.792 too low. | 736f53808c2babfa312c8da29be02102 | 794 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 57 | 114 | 1.3E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/27845|m.8926 | UnnamedSample_HQ_transcript/27845 | Coverage 0.792 too low. | 736f53808c2babfa312c8da29be02102 | 794 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 181 | 235 | 1.1E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/27845|m.8926 | UnnamedSample_HQ_transcript/27845 | Coverage 0.792 too low. | 736f53808c2babfa312c8da29be02102 | 794 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 243 | 300 | 3.4E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/27845|m.8926 | UnnamedSample_HQ_transcript/27845 | Coverage 0.792 too low. | 736f53808c2babfa312c8da29be02102 | 794 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 456 | 513 | 1.9E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/27845|m.8926 | UnnamedSample_HQ_transcript/27845 | Coverage 0.792 too low. | 736f53808c2babfa312c8da29be02102 | 794 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 574 | 677 | 1.5E-37 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/27845|m.8926 | UnnamedSample_HQ_transcript/27845 | Coverage 0.792 too low. | 736f53808c2babfa312c8da29be02102 | 794 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 682 | 792 | 1.5E-43 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/15277|m.5490 | UnnamedSample_HQ_transcript/15277 | Unmapped. | 77ca921c37ac88dbefe499182858111b | 1149 | Pfam | PF17222 | Viral cysteine endopeptidase C107 | 8 | 263 | 5.4E-11 | T | 22-09-2020 | IPR033777 | Viral cysteine endopeptidase C107 |
| UnnamedSample_HQ_transcript/63593|m.16753 | UnnamedSample_HQ_transcript/63593 | Coverage 0.782 too low. | e6fa392e7d3add84ac2da77cc5fc47e1 | 311 | Pfam | PF01490 | Transmembrane amino acid transporter protein | 3 | 271 | 6.8E-44 | T | 22-09-2020 | IPR013057 | Amino acid transporter, transmembrane domain |
| UnnamedSample_HQ_transcript/48362|m.13663 | UnnamedSample_HQ_transcript/48362 | Identity 0.634 too low. | 5ceb8b621ce4ab0b8a02873c1211ca70 | 406 | Pfam | PF02225 | PA domain | 37 | 129 | 7.3E-8 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/48362|m.13663 | UnnamedSample_HQ_transcript/48362 | Identity 0.634 too low. | 5ceb8b621ce4ab0b8a02873c1211ca70 | 406 | Pfam | PF13639 | Ring finger domain | 214 | 257 | 2.5E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/30474|m.9578 | UnnamedSample_HQ_transcript/30474 | Coverage 0.976 too low. | c6b6176e99598ecc6fdaecef5c56d7d4 | 882 | Pfam | PF05199 | GMC oxidoreductase | 513 | 635 | 5.8E-9 | T | 22-09-2020 | IPR007867 | Glucose-methanol-choline oxidoreductase, C-terminal |
| UnnamedSample_HQ_transcript/30474|m.9578 | UnnamedSample_HQ_transcript/30474 | Coverage 0.976 too low. | c6b6176e99598ecc6fdaecef5c56d7d4 | 882 | Pfam | PF00732 | GMC oxidoreductase | 317 | 405 | 6.6E-11 | T | 22-09-2020 | IPR000172 | Glucose-methanol-choline oxidoreductase, N-terminal |
| UnnamedSample_HQ_transcript/103|m.102 | UnnamedSample_HQ_transcript/103 | Unmapped. | 0b17fc9d7ec20918a4ad52ff7b9c18a6 | 1542 | Pfam | PF13086 | AAA domain | 190 | 260 | 7.4E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/103|m.102 | UnnamedSample_HQ_transcript/103 | Unmapped. | 0b17fc9d7ec20918a4ad52ff7b9c18a6 | 1542 | Pfam | PF13087 | AAA domain | 373 | 544 | 1.4E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/64368|m.16926 | UnnamedSample_HQ_transcript/64368 | Coverage 0.920 too low. | d8129bd1896bcdbe9ae5327c96e91d15 | 428 | Pfam | PF00013 | KH domain | 343 | 405 | 4.2E-16 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/64368|m.16926 | UnnamedSample_HQ_transcript/64368 | Coverage 0.920 too low. | d8129bd1896bcdbe9ae5327c96e91d15 | 428 | Pfam | PF00013 | KH domain | 30 | 88 | 9.8E-11 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/64368|m.16926 | UnnamedSample_HQ_transcript/64368 | Coverage 0.920 too low. | d8129bd1896bcdbe9ae5327c96e91d15 | 428 | Pfam | PF00013 | KH domain | 120 | 181 | 3.5E-14 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/83800|m.20314 | UnnamedSample_HQ_transcript/83800 | Coverage 0.893 too low. | d8129bd1896bcdbe9ae5327c96e91d15 | 428 | Pfam | PF00013 | KH domain | 343 | 405 | 4.2E-16 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/83800|m.20314 | UnnamedSample_HQ_transcript/83800 | Coverage 0.893 too low. | d8129bd1896bcdbe9ae5327c96e91d15 | 428 | Pfam | PF00013 | KH domain | 30 | 88 | 9.8E-11 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/83800|m.20314 | UnnamedSample_HQ_transcript/83800 | Coverage 0.893 too low. | d8129bd1896bcdbe9ae5327c96e91d15 | 428 | Pfam | PF00013 | KH domain | 120 | 181 | 3.5E-14 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/83675|m.20291 | UnnamedSample_HQ_transcript/83675 | Coverage 0.915 too low. | d8129bd1896bcdbe9ae5327c96e91d15 | 428 | Pfam | PF00013 | KH domain | 343 | 405 | 4.2E-16 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/83675|m.20291 | UnnamedSample_HQ_transcript/83675 | Coverage 0.915 too low. | d8129bd1896bcdbe9ae5327c96e91d15 | 428 | Pfam | PF00013 | KH domain | 30 | 88 | 9.8E-11 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/83675|m.20291 | UnnamedSample_HQ_transcript/83675 | Coverage 0.915 too low. | d8129bd1896bcdbe9ae5327c96e91d15 | 428 | Pfam | PF00013 | KH domain | 120 | 181 | 3.5E-14 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/32966|m.10205 | UnnamedSample_HQ_transcript/32966 | Identity 0.949 too low. | 5c63b7f7229b7612e43ab699ccd4ff7e | 406 | Pfam | PF01204 | Trehalase | 1 | 371 | 1.6E-110 | T | 22-09-2020 | IPR001661 | Glycoside hydrolase, family 37 |
| UnnamedSample_HQ_transcript/47054|m.13380 | UnnamedSample_HQ_transcript/47054 | Identity 0.939 too low. | 5c63b7f7229b7612e43ab699ccd4ff7e | 406 | Pfam | PF01204 | Trehalase | 1 | 371 | 1.6E-110 | T | 22-09-2020 | IPR001661 | Glycoside hydrolase, family 37 |
| UnnamedSample_HQ_transcript/69324|m.17814 | UnnamedSample_HQ_transcript/69324 | Coverage 0.944 too low. | a9063b488097e438ae0ae5a814307b45 | 486 | Pfam | PF03022 | Major royal jelly protein | 129 | 416 | 1.8E-71 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/66096|m.17232 | UnnamedSample_HQ_transcript/66096 | Identity 0.927 too low. | a9063b488097e438ae0ae5a814307b45 | 486 | Pfam | PF03022 | Major royal jelly protein | 129 | 416 | 1.8E-71 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/64121|m.16866 | UnnamedSample_HQ_transcript/64121 | Coverage 0.906 too low. | a9063b488097e438ae0ae5a814307b45 | 486 | Pfam | PF03022 | Major royal jelly protein | 129 | 416 | 1.8E-71 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/71151|m.18137 | UnnamedSample_HQ_transcript/71151 | Coverage 0.957 too low. | a9063b488097e438ae0ae5a814307b45 | 486 | Pfam | PF03022 | Major royal jelly protein | 129 | 416 | 1.8E-71 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/60582|m.16175 | UnnamedSample_HQ_transcript/60582 | Identity 0.932 too low. | a9063b488097e438ae0ae5a814307b45 | 486 | Pfam | PF03022 | Major royal jelly protein | 129 | 416 | 1.8E-71 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/67512|m.17496 | UnnamedSample_HQ_transcript/67512 | Coverage 0.918 too low. | a9063b488097e438ae0ae5a814307b45 | 486 | Pfam | PF03022 | Major royal jelly protein | 129 | 416 | 1.8E-71 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/71765|m.18264 | UnnamedSample_HQ_transcript/71765 | Coverage 0.902 too low. | a9063b488097e438ae0ae5a814307b45 | 486 | Pfam | PF03022 | Major royal jelly protein | 129 | 416 | 1.8E-71 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/16038|m.5718 | UnnamedSample_HQ_transcript/16038 | Coverage 0.076 too low. | 26faa0bc700d9b0a0d74215943ddad1a | 847 | Pfam | PF00013 | KH domain | 575 | 636 | 1.4E-10 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/16038|m.5718 | UnnamedSample_HQ_transcript/16038 | Coverage 0.076 too low. | 26faa0bc700d9b0a0d74215943ddad1a | 847 | Pfam | PF00567 | Tudor domain | 673 | 793 | 1.8E-22 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/3426|m.1600 | UnnamedSample_HQ_transcript/3426 | Coverage 0.053 too low. | 26faa0bc700d9b0a0d74215943ddad1a | 847 | Pfam | PF00013 | KH domain | 575 | 636 | 1.4E-10 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/3426|m.1600 | UnnamedSample_HQ_transcript/3426 | Coverage 0.053 too low. | 26faa0bc700d9b0a0d74215943ddad1a | 847 | Pfam | PF00567 | Tudor domain | 673 | 793 | 1.8E-22 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/68672|m.17702 | UnnamedSample_HQ_transcript/68672 | Unmapped. | c408df1ecf04b8393b6868f089f1f0d2 | 528 | Pfam | PF02272 | DHHA1 domain | 322 | 453 | 1.0E-19 | T | 22-09-2020 | IPR003156 | DHHA1 domain |
| UnnamedSample_HQ_transcript/68672|m.17702 | UnnamedSample_HQ_transcript/68672 | Unmapped. | c408df1ecf04b8393b6868f089f1f0d2 | 528 | Pfam | PF01368 | DHH family | 74 | 206 | 3.5E-9 | T | 22-09-2020 | IPR001667 | DDH domain |
| UnnamedSample_HQ_transcript/74942|m.18822 | UnnamedSample_HQ_transcript/74942 | Coverage 0.978 too low. | c27850cd83f28febba88b584ad7040af | 266 | Pfam | PF08598 | Sds3-like | 71 | 213 | 6.7E-16 | T | 22-09-2020 | IPR013907 | Sds3-like |
| UnnamedSample_HQ_transcript/15209|m.5466 | UnnamedSample_HQ_transcript/15209 | Coverage 0.670 too low. | 52869278998fa049ed0b1b27f072430b | 994 | Pfam | PF13855 | Leucine rich repeat | 353 | 412 | 3.6E-13 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/15209|m.5466 | UnnamedSample_HQ_transcript/15209 | Coverage 0.670 too low. | 52869278998fa049ed0b1b27f072430b | 994 | Pfam | PF13855 | Leucine rich repeat | 232 | 292 | 2.9E-9 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/15209|m.5466 | UnnamedSample_HQ_transcript/15209 | Coverage 0.670 too low. | 52869278998fa049ed0b1b27f072430b | 994 | Pfam | PF13855 | Leucine rich repeat | 163 | 220 | 2.0E-12 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/15209|m.5466 | UnnamedSample_HQ_transcript/15209 | Coverage 0.670 too low. | 52869278998fa049ed0b1b27f072430b | 994 | Pfam | PF13676 | TIR domain | 831 | 939 | 6.6E-15 | T | 22-09-2020 | IPR000157 | Toll/interleukin-1 receptor homology (TIR) domain |
| UnnamedSample_HQ_transcript/52691|m.14582 | UnnamedSample_HQ_transcript/52691 | Coverage 0.220 too low. | b784639245d64c4f961e02e1e4af4ea1 | 626 | Pfam | PF00169 | PH domain | 51 | 149 | 7.1E-12 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/52691|m.14582 | UnnamedSample_HQ_transcript/52691 | Coverage 0.220 too low. | b784639245d64c4f961e02e1e4af4ea1 | 626 | Pfam | PF00169 | PH domain | 334 | 429 | 8.9E-13 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/4653|m.2053 | UnnamedSample_HQ_transcript/4653 | Unmapped. | c5656d2b9791a32f045443ee6d437fc3 | 1601 | Pfam | PF00910 | RNA helicase | 1219 | 1327 | 5.8E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/4653|m.2053 | UnnamedSample_HQ_transcript/4653 | Unmapped. | c5656d2b9791a32f045443ee6d437fc3 | 1601 | Pfam | PF08762 | CRPV capsid protein like | 595 | 805 | 8.9E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/10200|m.3892 | UnnamedSample_HQ_transcript/10200 | Coverage 0.443 too low. | 028c51645f2befb3a5ba9eea057f8d4b | 1159 | Pfam | PF00439 | Bromodomain | 343 | 423 | 4.8E-15 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/75879|m.18995 | UnnamedSample_HQ_transcript/75879 | Coverage 0.793 too low. | b62ea178f2eef3ecc74052670bb6be51 | 424 | Pfam | PF13894 | C2H2-type zinc finger | 395 | 418 | 3.0E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/75879|m.18995 | UnnamedSample_HQ_transcript/75879 | Coverage 0.793 too low. | b62ea178f2eef3ecc74052670bb6be51 | 424 | Pfam | PF00096 | Zinc finger, C2H2 type | 365 | 386 | 0.0024 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/75879|m.18995 | UnnamedSample_HQ_transcript/75879 | Coverage 0.793 too low. | b62ea178f2eef3ecc74052670bb6be51 | 424 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.4E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/3291|m.1562 | UnnamedSample_HQ_transcript/3291 | Identity 0.556 too low. | e44a165887234c268d96abb962a8ce44 | 723 | Pfam | PF00069 | Protein kinase domain | 25 | 289 | 3.4E-61 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/75024|m.18848 | UnnamedSample_HQ_transcript/75024 | Coverage 0.186 too low. | 8e603e7ed0154d0be6a57491bf8aab7f | 438 | Pfam | PF02931 | Neurotransmitter-gated ion-channel ligand binding domain | 36 | 244 | 1.9E-41 | T | 22-09-2020 | IPR006202 | Neurotransmitter-gated ion-channel ligand-binding domain |
| UnnamedSample_HQ_transcript/75024|m.18848 | UnnamedSample_HQ_transcript/75024 | Coverage 0.186 too low. | 8e603e7ed0154d0be6a57491bf8aab7f | 438 | Pfam | PF02932 | Neurotransmitter-gated ion-channel transmembrane region | 254 | 354 | 8.8E-28 | T | 22-09-2020 | IPR006029 | Neurotransmitter-gated ion-channel transmembrane domain |
| UnnamedSample_HQ_transcript/58148|m.15685 | UnnamedSample_HQ_transcript/58148 | Coverage 0.091 too low. | 2a7e5202e179da4b1bf8417ff237fbe6 | 433 | Pfam | PF06839 | GRF zinc finger | 298 | 342 | 3.5E-14 | T | 22-09-2020 | IPR010666 | Zinc finger, GRF-type |
| UnnamedSample_HQ_transcript/58148|m.15685 | UnnamedSample_HQ_transcript/58148 | Coverage 0.091 too low. | 2a7e5202e179da4b1bf8417ff237fbe6 | 433 | Pfam | PF06839 | GRF zinc finger | 390 | 433 | 4.2E-13 | T | 22-09-2020 | IPR010666 | Zinc finger, GRF-type |
| UnnamedSample_HQ_transcript/66240|m.17255 | UnnamedSample_HQ_transcript/66240 | Coverage 0.065 too low. | 2a7e5202e179da4b1bf8417ff237fbe6 | 433 | Pfam | PF06839 | GRF zinc finger | 298 | 342 | 3.5E-14 | T | 22-09-2020 | IPR010666 | Zinc finger, GRF-type |
| UnnamedSample_HQ_transcript/66240|m.17255 | UnnamedSample_HQ_transcript/66240 | Coverage 0.065 too low. | 2a7e5202e179da4b1bf8417ff237fbe6 | 433 | Pfam | PF06839 | GRF zinc finger | 390 | 433 | 4.2E-13 | T | 22-09-2020 | IPR010666 | Zinc finger, GRF-type |
| UnnamedSample_HQ_transcript/63410|m.16715 | UnnamedSample_HQ_transcript/63410 | Coverage 0.064 too low. | 2a7e5202e179da4b1bf8417ff237fbe6 | 433 | Pfam | PF06839 | GRF zinc finger | 298 | 342 | 3.5E-14 | T | 22-09-2020 | IPR010666 | Zinc finger, GRF-type |
| UnnamedSample_HQ_transcript/63410|m.16715 | UnnamedSample_HQ_transcript/63410 | Coverage 0.064 too low. | 2a7e5202e179da4b1bf8417ff237fbe6 | 433 | Pfam | PF06839 | GRF zinc finger | 390 | 433 | 4.2E-13 | T | 22-09-2020 | IPR010666 | Zinc finger, GRF-type |
| UnnamedSample_HQ_transcript/64359|m.16922 | UnnamedSample_HQ_transcript/64359 | Coverage 0.065 too low. | 2a7e5202e179da4b1bf8417ff237fbe6 | 433 | Pfam | PF06839 | GRF zinc finger | 298 | 342 | 3.5E-14 | T | 22-09-2020 | IPR010666 | Zinc finger, GRF-type |
| UnnamedSample_HQ_transcript/64359|m.16922 | UnnamedSample_HQ_transcript/64359 | Coverage 0.065 too low. | 2a7e5202e179da4b1bf8417ff237fbe6 | 433 | Pfam | PF06839 | GRF zinc finger | 390 | 433 | 4.2E-13 | T | 22-09-2020 | IPR010666 | Zinc finger, GRF-type |
| UnnamedSample_HQ_transcript/63651|m.16768 | UnnamedSample_HQ_transcript/63651 | Coverage 0.064 too low. | 2a7e5202e179da4b1bf8417ff237fbe6 | 433 | Pfam | PF06839 | GRF zinc finger | 298 | 342 | 3.5E-14 | T | 22-09-2020 | IPR010666 | Zinc finger, GRF-type |
| UnnamedSample_HQ_transcript/63651|m.16768 | UnnamedSample_HQ_transcript/63651 | Coverage 0.064 too low. | 2a7e5202e179da4b1bf8417ff237fbe6 | 433 | Pfam | PF06839 | GRF zinc finger | 390 | 433 | 4.2E-13 | T | 22-09-2020 | IPR010666 | Zinc finger, GRF-type |
| UnnamedSample_HQ_transcript/40177|m.11879 | UnnamedSample_HQ_transcript/40177 | Coverage 0.636 too low. | c4e08be8b6fae5e8e9ed4a601f326e79 | 461 | Pfam | PF03098 | Animal haem peroxidase | 77 | 460 | 1.3E-105 | T | 22-09-2020 | IPR019791 | Haem peroxidase, animal-type |
| UnnamedSample_HQ_transcript/104860|m.23216 | UnnamedSample_HQ_transcript/104860 | Coverage 0.965 too low. | 22981ed14da0d7ead9dcf0f343d9bd0e | 117 | Pfam | PF07679 | Immunoglobulin I-set domain | 5 | 57 | 2.1E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/25990|m.8477 | UnnamedSample_HQ_transcript/25990 | Coverage 0.792 too low. | 607187298c6e0400587b79c58ad55d72 | 848 | Pfam | PF01576 | Myosin tail | 110 | 818 | 9.5E-61 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/53841|m.14811 | UnnamedSample_HQ_transcript/53841 | Coverage 0.818 too low. | e6c0a6b9177b1046ef8cfab4fb594380 | 684 | Pfam | PF00069 | Protein kinase domain | 615 | 680 | 2.5E-8 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/17945|m.6284 | UnnamedSample_HQ_transcript/17945 | Coverage 0.972 too low. | 41ad0905ac097b1b5a77c0b49dbaf98e | 545 | Pfam | PF05380 | Pao retrotransposon peptidase | 279 | 440 | 3.4E-47 | T | 22-09-2020 | IPR008042 | Retrotransposon, Pao |
| UnnamedSample_HQ_transcript/63905|m.16825 | UnnamedSample_HQ_transcript/63905 | Coverage 0.950 too low. | 41ad0905ac097b1b5a77c0b49dbaf98e | 545 | Pfam | PF05380 | Pao retrotransposon peptidase | 279 | 440 | 3.4E-47 | T | 22-09-2020 | IPR008042 | Retrotransposon, Pao |
| UnnamedSample_HQ_transcript/117992|m.24674 | UnnamedSample_HQ_transcript/117992 | Coverage 0.840 too low. | 95b2743dfabbdec7c7d77f7fc85508c4 | 159 | Pfam | PF15430 | Single domain von Willebrand factor type C | 52 | 129 | 2.1E-13 | T | 22-09-2020 | IPR029277 | Single domain Von Willebrand factor type C domain |
| UnnamedSample_HQ_transcript/105937|m.23329 | UnnamedSample_HQ_transcript/105937 | Coverage 0.887 too low. | 95b2743dfabbdec7c7d77f7fc85508c4 | 159 | Pfam | PF15430 | Single domain von Willebrand factor type C | 52 | 129 | 2.1E-13 | T | 22-09-2020 | IPR029277 | Single domain Von Willebrand factor type C domain |
| UnnamedSample_HQ_transcript/114305|m.24322 | UnnamedSample_HQ_transcript/114305 | Coverage 0.982 too low. | 95b2743dfabbdec7c7d77f7fc85508c4 | 159 | Pfam | PF15430 | Single domain von Willebrand factor type C | 52 | 129 | 2.1E-13 | T | 22-09-2020 | IPR029277 | Single domain Von Willebrand factor type C domain |
| UnnamedSample_HQ_transcript/114726|m.24375 | UnnamedSample_HQ_transcript/114726 | Coverage 0.856 too low. | 95b2743dfabbdec7c7d77f7fc85508c4 | 159 | Pfam | PF15430 | Single domain von Willebrand factor type C | 52 | 129 | 2.1E-13 | T | 22-09-2020 | IPR029277 | Single domain Von Willebrand factor type C domain |
| UnnamedSample_HQ_transcript/33303|m.10288 | UnnamedSample_HQ_transcript/33303 | Coverage 0.838 too low. | 9df7bdfc0f7f13782cb348a89a4fd606 | 718 | Pfam | PF04146 | YT521-B-like domain | 436 | 571 | 4.7E-41 | T | 22-09-2020 | IPR007275 | YTH domain |
| UnnamedSample_HQ_transcript/24296|m.8020 | UnnamedSample_HQ_transcript/24296 | Coverage 0.741 too low. | 9df7bdfc0f7f13782cb348a89a4fd606 | 718 | Pfam | PF04146 | YT521-B-like domain | 436 | 571 | 4.7E-41 | T | 22-09-2020 | IPR007275 | YTH domain |
| UnnamedSample_HQ_transcript/24072|m.7963 | UnnamedSample_HQ_transcript/24072 | Coverage 0.723 too low. | 9df7bdfc0f7f13782cb348a89a4fd606 | 718 | Pfam | PF04146 | YT521-B-like domain | 436 | 571 | 4.7E-41 | T | 22-09-2020 | IPR007275 | YTH domain |
| UnnamedSample_HQ_transcript/33886|m.10432 | UnnamedSample_HQ_transcript/33886 | Coverage 0.826 too low. | 9df7bdfc0f7f13782cb348a89a4fd606 | 718 | Pfam | PF04146 | YT521-B-like domain | 436 | 571 | 4.7E-41 | T | 22-09-2020 | IPR007275 | YTH domain |
| UnnamedSample_HQ_transcript/20772|m.7083 | UnnamedSample_HQ_transcript/20772 | Coverage 0.685 too low. | 9df7bdfc0f7f13782cb348a89a4fd606 | 718 | Pfam | PF04146 | YT521-B-like domain | 436 | 571 | 4.7E-41 | T | 22-09-2020 | IPR007275 | YTH domain |
| UnnamedSample_HQ_transcript/63493|m.16732 | UnnamedSample_HQ_transcript/63493 | Identity 0.748 too low. | bdc2f3ea8dfb6f22b6131acffc210541 | 527 | Pfam | PF00266 | Aminotransferase class-V | 24 | 463 | 2.9E-24 | T | 22-09-2020 | IPR000192 | Aminotransferase class V domain |
| UnnamedSample_HQ_transcript/37720|m.11326 | UnnamedSample_HQ_transcript/37720 | Identity 0.920 too low. | 6c28d242dfa4e9403a34c5c85058278b | 268 | Pfam | PF00408 | Phosphoglucomutase/phosphomannomutase, C-terminal domain | 175 | 242 | 2.4E-7 | T | 22-09-2020 | IPR005843 | Alpha-D-phosphohexomutase, C-terminal |
| UnnamedSample_HQ_transcript/37720|m.11326 | UnnamedSample_HQ_transcript/37720 | Identity 0.920 too low. | 6c28d242dfa4e9403a34c5c85058278b | 268 | Pfam | PF02880 | Phosphoglucomutase/phosphomannomutase, alpha/beta/alpha domain III | 13 | 126 | 1.5E-29 | T | 22-09-2020 | IPR005846 | Alpha-D-phosphohexomutase, alpha/beta/alpha domain III |
| UnnamedSample_HQ_transcript/41319|m.12121 | UnnamedSample_HQ_transcript/41319 | Identity 0.917 too low. | 6c28d242dfa4e9403a34c5c85058278b | 268 | Pfam | PF00408 | Phosphoglucomutase/phosphomannomutase, C-terminal domain | 175 | 242 | 2.4E-7 | T | 22-09-2020 | IPR005843 | Alpha-D-phosphohexomutase, C-terminal |
| UnnamedSample_HQ_transcript/41319|m.12121 | UnnamedSample_HQ_transcript/41319 | Identity 0.917 too low. | 6c28d242dfa4e9403a34c5c85058278b | 268 | Pfam | PF02880 | Phosphoglucomutase/phosphomannomutase, alpha/beta/alpha domain III | 13 | 126 | 1.5E-29 | T | 22-09-2020 | IPR005846 | Alpha-D-phosphohexomutase, alpha/beta/alpha domain III |
| UnnamedSample_HQ_transcript/57694|m.15591 | UnnamedSample_HQ_transcript/57694 | Coverage 0.627 too low. | 7270cac617c4dd7007f69698618af3c2 | 395 | Pfam | PF03194 | LUC7 N_terminus | 5 | 258 | 4.4E-92 | T | 22-09-2020 | IPR004882 | Luc7-related |
| UnnamedSample_HQ_transcript/41522|m.12163 | UnnamedSample_HQ_transcript/41522 | Coverage 0.520 too low. | 7270cac617c4dd7007f69698618af3c2 | 395 | Pfam | PF03194 | LUC7 N_terminus | 5 | 258 | 4.4E-92 | T | 22-09-2020 | IPR004882 | Luc7-related |
| UnnamedSample_HQ_transcript/100384|m.22696 | UnnamedSample_HQ_transcript/100384 | Coverage 0.822 too low. | 6735681d6b7cafd291858ed00bd37722 | 327 | Pfam | PF13193 | AMP-binding enzyme C-terminal domain | 233 | 309 | 2.1E-18 | T | 22-09-2020 | IPR025110 | AMP-binding enzyme, C-terminal domain |
| UnnamedSample_HQ_transcript/100384|m.22696 | UnnamedSample_HQ_transcript/100384 | Coverage 0.822 too low. | 6735681d6b7cafd291858ed00bd37722 | 327 | Pfam | PF00501 | AMP-binding enzyme | 15 | 224 | 3.6E-54 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/115965|m.24490 | UnnamedSample_HQ_transcript/115965 | Coverage 0.985 too low. | d4659b857928f9b98656dd3daf3c8756 | 149 | Pfam | PF00022 | Actin | 4 | 149 | 6.2E-61 | T | 22-09-2020 | IPR004000 | Actin family |
| UnnamedSample_HQ_transcript/73246|m.18515 | UnnamedSample_HQ_transcript/73246 | Coverage 0.768 too low. | 6941f50d6c506179b329d044e14264fb | 287 | Pfam | PF01048 | Phosphorylase superfamily | 16 | 252 | 6.2E-43 | T | 22-09-2020 | IPR000845 | Nucleoside phosphorylase domain |
| UnnamedSample_HQ_transcript/80785|m.19833 | UnnamedSample_HQ_transcript/80785 | Coverage 0.856 too low. | 6941f50d6c506179b329d044e14264fb | 287 | Pfam | PF01048 | Phosphorylase superfamily | 16 | 252 | 6.2E-43 | T | 22-09-2020 | IPR000845 | Nucleoside phosphorylase domain |
| UnnamedSample_HQ_transcript/42414|m.12355 | UnnamedSample_HQ_transcript/42414 | Coverage 0.080 too low. | d03eaf15b9ba7a7617587f7ef5b27e6c | 568 | Pfam | PF09820 | Predicted AAA-ATPase | 43 | 323 | 3.6E-56 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/66376|m.17287 | UnnamedSample_HQ_transcript/66376 | Coverage 0.106 too low. | d03eaf15b9ba7a7617587f7ef5b27e6c | 568 | Pfam | PF09820 | Predicted AAA-ATPase | 43 | 323 | 3.6E-56 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/33390|m.10311 | UnnamedSample_HQ_transcript/33390 | Identity 0.814 too low. | d4c830a7c47e4f43f717927ba597fc65 | 677 | Pfam | PF01658 | Myo-inositol-1-phosphate synthase | 307 | 420 | 8.3E-42 | T | 22-09-2020 | IPR013021 | Myo-inositol-1-phosphate synthase, GAPDH-like |
| UnnamedSample_HQ_transcript/33390|m.10311 | UnnamedSample_HQ_transcript/33390 | Identity 0.814 too low. | d4c830a7c47e4f43f717927ba597fc65 | 677 | Pfam | PF07994 | Myo-inositol-1-phosphate synthase | 57 | 490 | 1.2E-136 | T | 22-09-2020 | IPR002587 | Myo-inositol-1-phosphate synthase |
| UnnamedSample_HQ_transcript/63716|m.16777 | UnnamedSample_HQ_transcript/63716 | Coverage 0.426 too low. | 41eb86e3bf4e1b87ad1ecfc162d5bb35 | 319 | Pfam | PF00804 | Syntaxin | 34 | 214 | 4.2E-49 | T | 22-09-2020 | IPR006011 | Syntaxin, N-terminal domain |
| UnnamedSample_HQ_transcript/63716|m.16777 | UnnamedSample_HQ_transcript/63716 | Coverage 0.426 too low. | 41eb86e3bf4e1b87ad1ecfc162d5bb35 | 319 | Pfam | PF05827 | Vacuolar ATP synthase subunit S1 (ATP6S1) | 205 | 316 | 9.4E-24 | T | 22-09-2020 | IPR008388 | ATPase, V1 complex, subunit S1 |
| UnnamedSample_HQ_transcript/2510|m.1236 | UnnamedSample_HQ_transcript/2510 | Identity 0.903 too low. | 21a4f8bf6dbf8bb0e617062b5e4b6dde | 1182 | Pfam | PF00373 | FERM central domain | 285 | 405 | 8.9E-6 | T | 22-09-2020 | IPR019748 | FERM central domain |
| UnnamedSample_HQ_transcript/2510|m.1236 | UnnamedSample_HQ_transcript/2510 | Identity 0.903 too low. | 21a4f8bf6dbf8bb0e617062b5e4b6dde | 1182 | Pfam | PF03623 | Focal adhesion targeting region | 1002 | 1133 | 2.9E-56 | T | 22-09-2020 | IPR005189 | Focal adhesion kinase, targeting (FAT) domain |
| UnnamedSample_HQ_transcript/2510|m.1236 | UnnamedSample_HQ_transcript/2510 | Identity 0.903 too low. | 21a4f8bf6dbf8bb0e617062b5e4b6dde | 1182 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 554 | 815 | 4.6E-91 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/2510|m.1236 | UnnamedSample_HQ_transcript/2510 | Identity 0.903 too low. | 21a4f8bf6dbf8bb0e617062b5e4b6dde | 1182 | Pfam | PF18038 | FERM N-terminal domain | 196 | 276 | 2.6E-18 | T | 22-09-2020 | IPR041390 | Focal adhesion kinase, N-terminal |
| UnnamedSample_HQ_transcript/57214|m.15489 | UnnamedSample_HQ_transcript/57214 | Identity 0.939 too low. | 69ed6678773621286e85c1c811230657 | 534 | Pfam | PF00012 | Hsp70 protein | 7 | 529 | 9.1E-208 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/40529|m.11963 | UnnamedSample_HQ_transcript/40529 | Identity 0.939 too low. | 69ed6678773621286e85c1c811230657 | 534 | Pfam | PF00012 | Hsp70 protein | 7 | 529 | 9.1E-208 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/44204|m.12760 | UnnamedSample_HQ_transcript/44204 | Identity 0.943 too low. | 69ed6678773621286e85c1c811230657 | 534 | Pfam | PF00012 | Hsp70 protein | 7 | 529 | 9.1E-208 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/99066|m.22503 | UnnamedSample_HQ_transcript/99066 | Coverage 0.984 too low. | e5b95fee5aa32c865130ac912ebbdcca | 342 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 262 | 325 | 1.9E-6 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/110877|m.23947 | UnnamedSample_HQ_transcript/110877 | Identity 0.857 too low. | 26408ce1d7140c69469d25d99d5a0356 | 276 | Pfam | PF00390 | Malic enzyme, N-terminal domain | 99 | 276 | 1.5E-77 | T | 22-09-2020 | IPR012301 | Malic enzyme, N-terminal domain |
| UnnamedSample_HQ_transcript/64948|m.17022 | UnnamedSample_HQ_transcript/64948 | Coverage 0.299 too low. | d79d4ac2b16cdff17423ddacd43c706e | 449 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.5E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/64948|m.17022 | UnnamedSample_HQ_transcript/64948 | Coverage 0.299 too low. | d79d4ac2b16cdff17423ddacd43c706e | 449 | Pfam | PF12874 | Zinc-finger of C2H2 type | 421 | 440 | 9.4E-5 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/69549|m.17851 | UnnamedSample_HQ_transcript/69549 | Coverage 0.382 too low. | 41aafdadc58deb02d3f3bee382aa6c85 | 420 | Pfam | PF00651 | BTB/POZ domain | 23 | 121 | 1.0E-22 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/49913|m.14004 | UnnamedSample_HQ_transcript/49913 | Identity 0.917 too low. | 0c7738cabae066291b9a7e6ad0d4c5b3 | 152 | Pfam | PF00006 | ATP synthase alpha/beta family, nucleotide-binding domain | 1 | 110 | 7.2E-9 | T | 22-09-2020 | IPR000194 | ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain |
| UnnamedSample_HQ_transcript/27604|m.8861 | UnnamedSample_HQ_transcript/27604 | Coverage 0.748 too low. | 27f9d71e902969f853962f471ae302c6 | 794 | Pfam | PF07679 | Immunoglobulin I-set domain | 25 | 98 | 2.2E-7 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/27604|m.8861 | UnnamedSample_HQ_transcript/27604 | Coverage 0.748 too low. | 27f9d71e902969f853962f471ae302c6 | 794 | Pfam | PF07679 | Immunoglobulin I-set domain | 197 | 280 | 2.7E-12 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/27604|m.8861 | UnnamedSample_HQ_transcript/27604 | Coverage 0.748 too low. | 27f9d71e902969f853962f471ae302c6 | 794 | Pfam | PF07679 | Immunoglobulin I-set domain | 673 | 754 | 5.6E-15 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/27604|m.8861 | UnnamedSample_HQ_transcript/27604 | Coverage 0.748 too low. | 27f9d71e902969f853962f471ae302c6 | 794 | Pfam | PF07679 | Immunoglobulin I-set domain | 297 | 373 | 1.4E-11 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/27604|m.8861 | UnnamedSample_HQ_transcript/27604 | Coverage 0.748 too low. | 27f9d71e902969f853962f471ae302c6 | 794 | Pfam | PF07679 | Immunoglobulin I-set domain | 107 | 192 | 1.4E-12 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/27604|m.8861 | UnnamedSample_HQ_transcript/27604 | Coverage 0.748 too low. | 27f9d71e902969f853962f471ae302c6 | 794 | Pfam | PF07679 | Immunoglobulin I-set domain | 574 | 660 | 2.1E-17 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/27604|m.8861 | UnnamedSample_HQ_transcript/27604 | Coverage 0.748 too low. | 27f9d71e902969f853962f471ae302c6 | 794 | Pfam | PF07679 | Immunoglobulin I-set domain | 382 | 467 | 1.3E-17 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/27604|m.8861 | UnnamedSample_HQ_transcript/27604 | Coverage 0.748 too low. | 27f9d71e902969f853962f471ae302c6 | 794 | Pfam | PF00041 | Fibronectin type III domain | 475 | 556 | 1.2E-15 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/82793|m.20158 | UnnamedSample_HQ_transcript/82793 | Coverage 0.184 too low. | 073e728938d660556195d70eb9f7be9f | 465 | Pfam | PF06441 | Epoxide hydrolase N terminus | 46 | 155 | 7.0E-31 | T | 22-09-2020 | IPR010497 | Epoxide hydrolase, N-terminal |
| UnnamedSample_HQ_transcript/51954|m.14446 | UnnamedSample_HQ_transcript/51954 | Coverage 0.337 too low. | 073e728938d660556195d70eb9f7be9f | 465 | Pfam | PF06441 | Epoxide hydrolase N terminus | 46 | 155 | 7.0E-31 | T | 22-09-2020 | IPR010497 | Epoxide hydrolase, N-terminal |
| UnnamedSample_HQ_transcript/56840|m.15414 | UnnamedSample_HQ_transcript/56840 | Coverage 0.375 too low. | 073e728938d660556195d70eb9f7be9f | 465 | Pfam | PF06441 | Epoxide hydrolase N terminus | 46 | 155 | 7.0E-31 | T | 22-09-2020 | IPR010497 | Epoxide hydrolase, N-terminal |
| UnnamedSample_HQ_transcript/76953|m.19196 | UnnamedSample_HQ_transcript/76953 | Coverage 0.209 too low. | 073e728938d660556195d70eb9f7be9f | 465 | Pfam | PF06441 | Epoxide hydrolase N terminus | 46 | 155 | 7.0E-31 | T | 22-09-2020 | IPR010497 | Epoxide hydrolase, N-terminal |
| UnnamedSample_HQ_transcript/20856|m.7107 | UnnamedSample_HQ_transcript/20856 | Coverage 0.987 too low. | 9be6413d84154647f95f8f2699083c53 | 650 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 235 | 504 | 1.6E-87 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/75029|m.18850 | UnnamedSample_HQ_transcript/75029 | Identity 0.944 too low. | 0823ffbe88e47971f9517c6fe9c81388 | 141 | Pfam | PF00012 | Hsp70 protein | 7 | 140 | 2.5E-54 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/75576|m.18952 | UnnamedSample_HQ_transcript/75576 | Coverage 0.089 too low. | b33c896785cb0aaaf1758c6f39b7c7e2 | 479 | Pfam | PF02170 | PAZ domain | 330 | 455 | 4.3E-30 | T | 22-09-2020 | IPR003100 | PAZ domain |
| UnnamedSample_HQ_transcript/69954|m.17923 | UnnamedSample_HQ_transcript/69954 | Coverage 0.139 too low. | b33c896785cb0aaaf1758c6f39b7c7e2 | 479 | Pfam | PF02170 | PAZ domain | 330 | 455 | 4.3E-30 | T | 22-09-2020 | IPR003100 | PAZ domain |
| UnnamedSample_HQ_transcript/101939|m.22862 | UnnamedSample_HQ_transcript/101939 | Coverage 0.990 too low. | 94f050ec02ea9ac65b03b5191f586b78 | 255 | Pfam | PF00876 | Innexin | 1 | 237 | 2.3E-60 | T | 22-09-2020 | IPR000990 | Innexin |
| UnnamedSample_HQ_transcript/82970|m.20194 | UnnamedSample_HQ_transcript/82970 | Coverage 0.201 too low. | dc2b2ceccb772897b6d5c619745ff8b3 | 409 | Pfam | PF00254 | FKBP-type peptidyl-prolyl cis-trans isomerase | 33 | 122 | 5.9E-31 | T | 22-09-2020 | IPR001179 | FKBP-type peptidyl-prolyl cis-trans isomerase domain |
| UnnamedSample_HQ_transcript/82970|m.20194 | UnnamedSample_HQ_transcript/82970 | Coverage 0.201 too low. | dc2b2ceccb772897b6d5c619745ff8b3 | 409 | Pfam | PF00254 | FKBP-type peptidyl-prolyl cis-trans isomerase | 151 | 236 | 3.3E-13 | T | 22-09-2020 | IPR001179 | FKBP-type peptidyl-prolyl cis-trans isomerase domain |
| UnnamedSample_HQ_transcript/82970|m.20194 | UnnamedSample_HQ_transcript/82970 | Coverage 0.201 too low. | dc2b2ceccb772897b6d5c619745ff8b3 | 409 | Pfam | PF00515 | Tetratricopeptide repeat | 341 | 373 | 5.5E-7 | T | 22-09-2020 | IPR001440 | Tetratricopeptide repeat 1 |
| UnnamedSample_HQ_transcript/93273|m.21706 | UnnamedSample_HQ_transcript/93273 | Coverage 0.075 too low. | dc2b2ceccb772897b6d5c619745ff8b3 | 409 | Pfam | PF00254 | FKBP-type peptidyl-prolyl cis-trans isomerase | 33 | 122 | 5.9E-31 | T | 22-09-2020 | IPR001179 | FKBP-type peptidyl-prolyl cis-trans isomerase domain |
| UnnamedSample_HQ_transcript/93273|m.21706 | UnnamedSample_HQ_transcript/93273 | Coverage 0.075 too low. | dc2b2ceccb772897b6d5c619745ff8b3 | 409 | Pfam | PF00254 | FKBP-type peptidyl-prolyl cis-trans isomerase | 151 | 236 | 3.3E-13 | T | 22-09-2020 | IPR001179 | FKBP-type peptidyl-prolyl cis-trans isomerase domain |
| UnnamedSample_HQ_transcript/93273|m.21706 | UnnamedSample_HQ_transcript/93273 | Coverage 0.075 too low. | dc2b2ceccb772897b6d5c619745ff8b3 | 409 | Pfam | PF00515 | Tetratricopeptide repeat | 341 | 373 | 5.5E-7 | T | 22-09-2020 | IPR001440 | Tetratricopeptide repeat 1 |
| UnnamedSample_HQ_transcript/88034|m.20941 | UnnamedSample_HQ_transcript/88034 | Coverage 0.122 too low. | dc2b2ceccb772897b6d5c619745ff8b3 | 409 | Pfam | PF00254 | FKBP-type peptidyl-prolyl cis-trans isomerase | 33 | 122 | 5.9E-31 | T | 22-09-2020 | IPR001179 | FKBP-type peptidyl-prolyl cis-trans isomerase domain |
| UnnamedSample_HQ_transcript/88034|m.20941 | UnnamedSample_HQ_transcript/88034 | Coverage 0.122 too low. | dc2b2ceccb772897b6d5c619745ff8b3 | 409 | Pfam | PF00254 | FKBP-type peptidyl-prolyl cis-trans isomerase | 151 | 236 | 3.3E-13 | T | 22-09-2020 | IPR001179 | FKBP-type peptidyl-prolyl cis-trans isomerase domain |
| UnnamedSample_HQ_transcript/88034|m.20941 | UnnamedSample_HQ_transcript/88034 | Coverage 0.122 too low. | dc2b2ceccb772897b6d5c619745ff8b3 | 409 | Pfam | PF00515 | Tetratricopeptide repeat | 341 | 373 | 5.5E-7 | T | 22-09-2020 | IPR001440 | Tetratricopeptide repeat 1 |
| UnnamedSample_HQ_transcript/89312|m.21129 | UnnamedSample_HQ_transcript/89312 | Coverage 0.674 too low. | 7a36115e95a0191c6383fcd0231cc7a3 | 425 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 37 | 425 | 1.8E-56 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/78226|m.19411 | UnnamedSample_HQ_transcript/78226 | Coverage 0.093 too low. | 3c699ac848712ffa61b0b60cba6db0e0 | 408 | Pfam | PF00168 | C2 domain | 38 | 129 | 7.5E-9 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/78226|m.19411 | UnnamedSample_HQ_transcript/78226 | Coverage 0.093 too low. | 3c699ac848712ffa61b0b60cba6db0e0 | 408 | Pfam | PF00168 | C2 domain | 296 | 401 | 5.8E-16 | T | 22-09-2020 | IPR000008 | C2 domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
